News

Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks
As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor ...
Devdiscourse5h
Global Health Updates: From Mergers to Measles and Medicine
The latest health-related developments include Merck's acquisition talks with SpringWorks, disbandment of a US Justice ...
Medical Dialogues7h
Merck KGaA in late-stage talks to acquire SpringWorks for USD 3.5 billion
Bengaluru: Merck KGaA, a science and technology company, is in late-stage negotiations to buy SpringWorks Therapeutics, a US ...
2 Outstanding Dividend Stocks to Buy and Hold For 20 Years
Many investors are withdrawing their money from the stock market right now, but those focused on the long term know to hold ...
Devdiscourse13h
Global Health Headlines: Mergers, Outbreaks, and Judicial Decisions Shake the Sector
Recent health news highlights Germany's Merck's acquisition talks with SpringWorks, U.S. Justice Department's disbanding of a ...
The American Journal of Managed Care2h
Pembrolizumab Before, After Surgery Improves Head and Neck Cancer Outcomes: Ravindra Uppaluri, MD, PhD
Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the potential of pembrolizumab (Keytruda; Merck) to improve outcomes following head and neck ...
3 Dividend ETFs to Buy With $2,000 and Hold Forever
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
No misses here: Healthcare earnings sweep past Wall Street estimates
All 16 S&P 500 healthcare companies that reported quarterly results this week, delivered an earnings beat. On the top-line, Gilead Sciences (NASDAQ:GILD) was the only one which missed Wall Street's ...